Like, it might be fine in rats and mice, but its toxic in people. A 2025 review of BPC-157 for musculoskeletal healing found an extensive animal literature but little clinical evidence supporting its use in people
None of the peptides currently being considered for compounding are FDA approved drugs, said Edgar Asebey, a life science attorney and partner at the Frier Levitt law firm who heads the FDA Practice Group
Inflammopharmacology 14 (5-6), 214221
BPC-157: experimental peptide creates risk for athletes
[20] For nutritional deficiency without intrinsic-factor loss, shorter courses-such as 30-100 mcg intramuscularly daily for five to ten days followed by 100-200 mcg monthly-are often sufficient
Joint pain and ligament injuries often result in inflammation and damage to the soft tissues, which can take a long time to heal without intervention